SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 0.009 50.666 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 51.937 46.195 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 99.002 20.614 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 120.589 23.805 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 145.179 15.836 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 161.886 18.754 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 182.193 17.526 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 200.452 12.201 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 213.695 76.365 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 290.828 9.898 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 301.391 87.935 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 390.060 14.710 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 405.384 2.969 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 409.206 1.570 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 412.278 60.205 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 473.097 3.976 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 477.807 15.188 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 494.684 28.959 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 524.292 37.679 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 563.148 14.130 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 578.302 10.017 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 589.121 31.877 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 621.681 54.352 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 676.920 29.812 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 707.654 13.038 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 721.340 11.553 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 733.797 46.058 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 780.486 1.587 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 783.166 63.208 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 847.295 6.365 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 854.923 2.389 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 857.995 10.563 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 869.394 9.369 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 879.548 0.461 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 881.169 9.915 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 887.790 0.034 <NA> <NA> SPEAKER_01 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 891.783 8.720 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 901.271 18.669 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 920.589 10.478 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 932.108 34.198 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 968.319 11.075 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 980.435 9.608 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 991.203 35.648 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 1027.517 34.556 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 1062.944 19.863 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 1083.490 26.894 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 1111.374 36.212 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 1148.319 37.014 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 1185.947 14.556 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 1201.408 0.205 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 1203.660 49.932 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 1254.224 27.423 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 1282.466 1.826 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 1285.026 14.949 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 1300.896 6.553 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 1308.114 23.942 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 1332.688 10.495 <NA> <NA> SPEAKER_00 <NA> <NA>
SPEAKER vt9fpd-fda-has-ended-authorization-for-monoclonal-antibodies-the-treatment-joe-rog 1 1345.452 30.887 <NA> <NA> SPEAKER_00 <NA> <NA>
